Le Lézard
Classified in: Health, Science and technology
Subjects: Product/Service, Award

MJH Life Sciencestm Publications Win Big at 2019 Folio: Eddie and Ozzie Awards Gala


MJH Life Sciencestm, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, is proud to announce that CURE® magazine, Cannabis Science and Technology and Medical Economics® won first place across a range of categories at this year's Folio: Eddie and Ozzie Awards gala on Oct. 30 at the New York Hilton Midtown.

For more than 25 years, the Eddie and Ozzie Awards have recognized excellence in uncompromising journalism and design.

"It is such an honor that several of our publications were recognized for their continued hard work over the past year providing top-quality content to our readers," said Mike Hennessy Jr., president and CEO of MJH Life Sciencestm. "This amazing achievement clearly demonstrates how our team collaborates to produce relevant and practical information that meets the needs of our diverse audience."

The winning publications are as follows:

In addition, honorable mentions were received by dvm360® for long-form feature content, graphic art, and editorial team of the year, Nutritional Outlook® for feature design, and CURE® magazine for podcast and single article.

View a full list of Eddie and Ozzie Award winners and finalists here.

About MJH Life Sciencestm

MJH Life Sciencestm is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit https://www.mjhlifesciences.com/.


These press releases may also interest you

at 10:06
Eisai Inc. presented the latest healthcare economic (HCEI) data for FYCOMPA® (perampanel) CIII at the 2019 American Epilepsy Society Annual Meeting in Baltimore, Maryland. Cumulatively, more than 35 scientific abstracts on FYCOMPA were presented by...

at 10:05
Xencor, Inc. , a clinical-stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer, autoimmune disease, asthma and allergic diseases, today announced initial data from its ongoing Phase 1 dose-escalation study of...

at 10:05
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced additional analyses of results from the ECHELON-1 and ECHELON-2 frontline phase 3 trials of ADCETRIS® (brentuximab vedotin). These analyses were...

at 10:05
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) ("Takeda"), today presented nine hematology poster presentations at the 61st American Society of Hematology (ASH) Annual Meeting that underscore its commitment to advancing treatments for...

at 10:05
Celularity, Inc. ("Celularity"), a clinical-stage cell therapeutics company focused on the development of innovative allogeneic cellular therapies derived from post partum human placentas, announced data introducing an extensive platform in...

at 10:05
Nektar Therapeutics today announced three presentations at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition for its IL-15 agonist and investigational candidate, NKTR-255. Data were presented from a number of preclinical...



News published on 13 november 2019 at 14:25 and distributed by: